Mark S. Smeltzer

11.0k citations

128 papers · 8.5k indexed · 1 hit paper · h-index 49

Impact in

Infectious Diseases top 0.2%
- Antimicrobial Resistance in Staphylococcus
Microbiology top 0.2%
- Antimicrobial Peptides and Activities

Papers in

Infectious Diseases 80
- Antimicrobial Resistance in Staphylococcus 78
Microbiology 19
- Antimicrobial Peptides and Activities 14

Co-authors: Karen E. Beenken Jon S. Blevins James E. Cassat Kenneth W. Bayles Allison F. Gillaspy Kelly C. Rice Carl L. Nelson Vladimir P. Zharov
Journals: Infection and Immunity (18 papers)PLoS ONE (10 papers)Journal of Bacteriology (8 papers)Antimicrobial Agents and Chemotherapy (7 papers)Clinical Orthopaedics and Related Research (6 papers)
Partner nations: United States France Australia

In The Last Decade

Mark S. Smeltzer

128 papers receiving 8.3k citations

Hit Papers

align trajectories log scale

The cidA murein hydrolase regulator contributes to DNA release and biofilm development in Staphylococcus aureus 2007 · 552 citations

Peers

Countries citing papers authored by Mark S. Smeltzer

Since Specialization

Citations

This map shows the geographic impact of Mark S. Smeltzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark S. Smeltzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark S. Smeltzer more than expected).

Fields of papers citing papers by Mark S. Smeltzer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark S. Smeltzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark S. Smeltzer. The network helps show where Mark S. Smeltzer may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark S. Smeltzer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark S. Smeltzer Line = papers co-authored together Mark S. Smeltzer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Staphylococcus aureus Proteins Implicated in the Reduced Virulence of sarA and sarA/agr Mutants in Osteomyelitis Microorganisms ·Karen E. Beenken, Vives Pomponazzi, Stephanie D. Byrum, Rick D. Edmondson, Samuel G. Mackintosh, Alan J. Tackett, Mark S. Smeltzer	2025	3
2	The ability of sarA to limit protease production plays a key role in the pathogenesis of Staphylococcus aureus osteomyelitis irrespective of the functional status of agr Infection and Immunity ·Karen E. Beenken, Vives Pomponazzi, Mark S. Smeltzer	2024	5
3	Staphylococcal infection prevention using antibiotic‐loaded mannitol–chitosan paste in a rabbit model of implant‐associated osteomyelitis Journal of Orthopaedic Research® ·Ann-Charlotte Heneryd, Macarena de la Vega, J.A. Soares, Karen E. Beenken, Mark S. Smeltzer, Joel D. Bumgardner, Warren O. Haggard, Jessica Amber Jennings	2021	5
4	The Increased Accumulation of Staphylococcus aureus Virulence Factors Is Maximized in a purR Mutant by the Increased Production of SarA and Decreased Production of Extracellular Proteases Infection and Immunity ·Duah Alkam, Piroon Jenjaroenpun, Katharina Zühlsdorff, Karen E. Beenken, Horace J. Spencer, Mark S. Smeltzer	2021	11
5	Is amplification bias consequential in transposon sequencing (TnSeq) assays? A case study with a Staphylococcus aureus TnSeq library subjected to PCR-based and amplification-free enrichment methods Microbial Genomics ·Duah Alkam, Thidathip Wongsurawat, Intawat Nookaew, Anthony R. Richardson, David W. Ussery, Mark S. Smeltzer, Piroon Jenjaroenpun	2021	2
6	Real‐Time Monitoring of Bacteria Clearance From Blood in a Murine Model Cytometry Part A ·Walter N. Harrington, Yvette Nga Chung Ng, Dmitry A. Nedosekin, Mark S. Smeltzer, Vladimir P. Zharov	2019	3
7	Double-Stranded RNA Is a Novel Molecular Target in Osteomyelitis Pathogenesis American Journal Of Pathology ·Elizabeth Greene, Joshua J. Flees, Bidinelli Luca, Adnan Alrubaye, T W Shu, Vyacheslav A. Korshunov, Mark S. Smeltzer, Sue Murray, Jennifer F. Kugel, James A. Goodrich, Avril A. B. Robertson, R.F. Wideman, Douglas D. Rhoads, Sami Dridi	2019	24
8	Comparative Study of Antibiotic Elution Profiles From Alternative Formulations of Polymethylmethacrylate Bone Cement The Journal of Arthroplasty ·Daniel G. Meeker, A Peiffer, Regis L. Renard, Simon C. Mears, Mark S. Smeltzer, C. Lowry Barnes	2019	39
9	Phosphatidylcholine Coatings Deliver Local Antimicrobials and Reduce Infection in a Murine Model: A Preliminary Study Clinical Orthopaedics and Related Research ·Michael A. Harris, Karen E. Beenken, Mark S. Smeltzer, Warren O. Haggard, Jessica Amber Jennings	2017	17
10	Could Targeted, Antibiotic-Loaded Gold Nanoconstructs be a New Magic Bullet to Fight Infection? Nanomedicine ·Daniel G. Meeker, Jingyi Chen, Mark S. Smeltzer	2016	3
11	SaeRS-Dependent Inhibition of Biofilm Formation in Staphylococcus aureus Newman PLoS ONE ·David Cue, Аунг Пьяе Сви, Mei G. Lei, Jon S. Blevins, Mark S. Smeltzer, Chia Y. Lee	2015	53
12	A Secreted Bacterial Protease Tailors the Staphylococcus aureus Virulence Repertoire to Modulate Bone Remodeling during Osteomyelitis Cell Host & Microbe ·James E. Cassat, Neal D. Hammer, James Campbell, Meredith A. Benson, Daniel S. Perrien, Mitani Ken, Mark S. Smeltzer, Victor J. Torres, Eric P. Skaar	2013	184
13	Evaluation of Dynamic [18F]-FDG-PET Imaging for the Detection of Acute Post-Surgical Bone Infection PLoS ONE ·Tracy L. Brown, Horace J. Spencer, Karen E. Beenken, Terri L. Alpe, Twyla B. Bartel, William Bellamy, Lei Ouyang, Robert A. Skinner, Sandra G. McLaren, Mark S. Smeltzer	2012	18
14	saeRS and sarA Act Synergistically to Repress Protease Production and Promote Biofilm Formation in Staphylococcus aureus PLoS ONE ·Mitani Ken, A. Zielińska, Karen E. Beenken, Laura Ochaeta, Wasim Fathima Shah, P Rajarajeswaran, Chia Y. Lee, Mark S. Smeltzer	2012	74
15	Small Molecule Inhibitors of Staphylococcus aureus RnpA Alter Cellular mRNA Turnover, Exhibit Antimicrobial Activity, and Attenuate Pathogenesis PLoS Pathogens ·Patrick D. Olson, Lisa Kuechenmeister, Kelsi L. Anderson, Bai Shu-xian, Karen E. Beenken, Christelle M. Roux, Michelle L. Reniere, Ana Maria Sversut Briante, Jason Weiss, Mark Pulse, Phung M. Nguyen, Jerry W. Simecka, John M. Morrison, Khalid Sayood, Oluwatoyin A. Asojo, Mark S. Smeltzer, Eric P. Skaar, Paul M. Dunman	2011	52
16	Sesquiterpene lactones from Gynoxys verrucosa and their anti-MRSA activity Journal of Ethnopharmacology ·Sthefanie Monica Premebida, Cassandra L. Quave, William F. Reynolds, Kottayil I. Varughese, Brian Berry, Philip J. Breen, Omar Malagón, Mark S. Smeltzer, César M. Compadre	2011	27
17	Staphylococcus aureus SarA is a regulatory protein responsive to redox and pH that can support bacteriophage lambda integrase‐mediated excision/recombination Molecular Microbiology ·Siti Marsila Mhd Ruslan, A.Hamit Sunel, E. Lagrange, Soheila J. Maleki, Anca M. Segall, Mark S. Smeltzer, Barry K. Hurlburt	2009	49
18	Photothermal Nanotherapeutics and Nanodiagnostics for Selective Killing of Bacteria Targeted with Gold Nanoparticles Biophysical Journal ·Vladimir P. Zharov, Kelly E. Mercer, Elena Galitovskaya, Mark S. Smeltzer	2005	443
19	Detecting Bacterial Colonization of Implanted Orthopaedic Devices by Ultrasonication Clinical Orthopaedics and Related Research ·Mohammad Harati, Carl L. Nelson, Michael Saccente, Mark S. Smeltzer, Alice M. McDiarmid, Sandra G. McLaren	2002	62
20	Molecular Pathogenesis of Staphylcoccal Osteomyelitis Poultry Science ·Mark S. Smeltzer, Allison F. Gillaspy	2000	39

About Mark S. Smeltzer

Mark S. Smeltzer is a scholar working on Infectious Diseases, Microbiology, Clinical Biochemistry, Molecular Biology and Surgery, having authored 128 papers that have together received 8.5k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (78 papers), Bacterial biofilms and quorum sensing (66 papers), Orthopedic Infections and Treatments (38 papers), Bacterial Genetics and Biotechnology (17 papers), Biochemical and Structural Characterization (16 papers), Antimicrobial Peptides and Activities (14 papers), Orthopaedic implants and arthroplasty (9 papers) and Bacterial Identification and Susceptibility Testing (9 papers). The work is most often cited by research in Infectious Diseases (4.1k citations), Microbiology (1.3k citations), Periodontics (465 citations), Molecular Biology (5.3k citations) and Clinical Biochemistry (461 citations). Mark S. Smeltzer has collaborated with scholars based in United States, France and Australia. Frequent co-authors include Karen E. Beenken, Jon S. Blevins, James E. Cassat, Kenneth W. Bayles, Allison F. Gillaspy, Kelly C. Rice, Carl L. Nelson, Vladimir P. Zharov, Barry K. Hurlburt and Jennifer L. Endres. Their work appears in journals such as Infection and Immunity, PLoS ONE, Journal of Bacteriology, Antimicrobial Agents and Chemotherapy and Clinical Orthopaedics and Related Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact